Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation.

Shin SH, Yahng SA, Yoon JH, Lee SE, Cho BS, Kim YJ.

Blood Res. 2013 Mar;48(1):55-7. doi: 10.5045/br.2013.48.1.55. Epub 2013 Mar 25.

2.

Altered metabolism of tacrolimus in hepatic veno-occlusive disease.

Mori T, Shimizu T, Yamazaki R, Nakazato T, Ikeda Y, Okamoto S.

Transpl Int. 2005 Oct;18(10):1215-7.

3.

BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation.

Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.

PMID:
24102514
4.

Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.

Sakaguchi H, Watanabe N, Muramatsu H, Doisaki S, Yoshida N, Matsumoto K, Kato K.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1118-25. doi: 10.1002/pbc.22645.

PMID:
20589662
5.

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.

Moscardó F, Sanz GF, de La Rubia J, Jiménez C, Saavedra S, Regadera A, Andreu R, García I, Plumé G, Martínez J, Martín G, Jarque I, Sanz MA.

Bone Marrow Transplant. 2001 May;27(9):983-8.

6.

[Delayed Hepatic Veno-Occlusive Disease after Haploidentical Hematopoietic Stem Cell Transplantation:A Report of Six Cases].

Kang HZ, Zheng XL, Wang ZD, Han DM, Ding L, Wang HX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1149-54. doi: 10.7534/j.issn.1009-2137.2016.04.035. Chinese.

PMID:
27531791
7.

Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.

Cheuk DK, Chiang AK, Ha SY, Chan GC.

Cochrane Database Syst Rev. 2015 May 27;(5):CD009311. doi: 10.1002/14651858.CD009311.pub2. Review.

PMID:
26017019
8.

Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.

Qureshi A, Marshall L, Lancaster D.

Pediatr Blood Cancer. 2008 Apr;50(4):831-2. doi: 10.1002/pbc.21425.

PMID:
18286502
9.

Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant.

Maximova N, Ferrara G, Minute M, Pizzol A, Kiren V, Montico M, Gregori M, Tamaro P.

Int J Hematol. 2014 Jun;99(6):766-72. doi: 10.1007/s12185-014-1578-y. Epub 2014 Apr 9.

PMID:
24715523
10.

Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.

Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2015 Feb;21(2):379-81. doi: 10.1016/j.bbmt.2014.09.026. Epub 2014 Oct 6.

11.

Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.

Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK, Barfield R.

J Pediatr Hematol Oncol. 2012 Apr;34(3):175-9. doi: 10.1097/MPH.0b013e3182427575.

PMID:
22395218
12.

Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.

Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Andreesen R, Kolb HJ, Holler E, Pihusch R.

Bone Marrow Transplant. 2005 Oct;36(7):631-7.

PMID:
16062176
13.
14.

Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.

Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Hiller E, Andreesen R, Kolb HJ, Holler E, Pihusch R.

Transplantation. 2005 Nov 27;80(10):1376-82.

PMID:
16340778
15.
16.

Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.

Tanikawa S, Mori S, Ohhashi K, Akiyama H, Sasaki T, Kaku H, Hiruma K, Matsunaga T, Morita T, Sakamaki H.

Bone Marrow Transplant. 2000 Oct;26(8):881-6.

18.
19.

Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.

Dalle JH, Giralt SA.

Biol Blood Marrow Transplant. 2016 Mar;22(3):400-9. doi: 10.1016/j.bbmt.2015.09.024. Epub 2015 Oct 23. Review.

20.

The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.

Carreras E, Díaz-Beyá M, Rosiñol L, Martínez C, Fernández-Avilés F, Rovira M.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1713-20. doi: 10.1016/j.bbmt.2011.06.006. Epub 2011 Jun 25.

Supplemental Content

Support Center